BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 6658120)

  • 1. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
    Garrido G; Bretó M; Pérez F; Berenguer J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid].
    Stiehl A; Czygan P; Fröhling W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical treatment of biliary lithiasis].
    Poupon R
    Chirurgie; 1987; 113(6):514-8. PubMed ID: 3436208
    [No Abstract]   [Full Text] [Related]  

  • 12. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 13. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
    Makino I; Yoneda M; Tamasawa N; Takebe K
    Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of cholesterol biliary lithiasis].
    Pomier-Layrargues G
    Union Med Can; 1984 Dec; 113(12):1003-5. PubMed ID: 6516056
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of biliary lithiasis].
    Lévy VG
    Rev Prat; 1982 Sep; 32(39-40):2585-90. PubMed ID: 7146799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of gallstones (author's transl)].
    Gérolami A; Montet JC; Marteau C; Reynier MO; Crotte C
    Gastroenterol Clin Biol; 1980; 4(8-9):588-99. PubMed ID: 7000610
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.